TECHNOLOGY TRANSFER AGREEMENT
This Agreement is entered into this 12 day of May, 2000 by and between
ERoyalty.net, Inc. ("ERN") and Molecular Robotics, Inc. ("MRI").
WHEREAS ERN has developed certain useful technologies ("Technologies") as
are listed on Schedule "A" attached to and incorporated into this Agreement;
and
WHEREAS ERN wants to assign all rights in the Technology to MRI as part
of a transaction where ERN together with several other owners of useful
technology will transfer their technologies to MRI so as to allow MRI to
exploit these technologies together; and
WHEREAS MRI will issue stock to this group of technology transferors,
including ERN, so that after the transfer this group together will own at least
80% of the outstanding shares of stock in MRI; and
WHEREAS ERN and MRI intend that this transfer be a tax-free transaction
under Section 351 of the Internal Revenue Code.
NOW THEREFORE ERN and MRI ("Party" or "Parties") agree as follows:
ERN warrants the following:
That it is the owner of the Technology listed on Schedule "A" to this
Agreement.
That it has all rights necessary in order to assign this Technology to MRI.
That this Technology is original and does not infringe any patent either issued
or pending or any trade secret held by any third party.
That the Technology is not subject to any license agreement nor is its transfer
subject to the approval of any third party.
That rights to the Technology have not been assigned or transferred previously
to any third party.
ERN hereby assigns to the Company exclusively throughout the world all right,
title and interest (choate or inchoate) in (i) the Technology listed on
Schedule A (ii) all precursors, portions and work in progress with respect
thereto and all inventions, works of authorship, mask works, technology,
information, know-how, materials and tools relating thereto or to the
development, support or maintenance thereof and (iii) all copyrights, patent
rights, trade secret rights, trademark rights, mask works rights and all other
intellectual and industrial property rights of any sort and all business,
contract rights, causes of action, and goodwill in, incorporated or embodied
in, used to develop, or related to any of the foregoing (collectively
"Intellectual Property") and MRI accepts such assignment.
MRI will issue to ERN 750,000 shares of MRI common stock.
ERN will assist MRI in any act necessary to show that MRI is the owner of the
technology including but not limited to any filings with the Patent and
Trademark Office.
ERN will indemnify and defend MRI against any claim of infringement arising out
of MRI's use of the Technology.
This Agreement shall be governed by the laws of the State of California as
though fully performed within that State.
Should a court of competent jurisdiction decide that any provision of this
Agreement is illegal or for any reason unenforceable, then the remaining
provisions of this Agreement shall remain fully effective and the remaining
provisions as a whole shall be interpreted so as to carry out the intention of
the Parties.
Any dispute over the interpretation of the terms or performance of the Parties
to this Agreement shall be heard in a court of competent jurisdiction within
Los Angeles, County, California.
The Parties have reviewed this Agreement and jointly agree to its terms and no
presumption shall be made against the drafter of any provision herein.
This Agreement may be executed in counterparts.
EROYALTY.NET, INC. MOLECULAR ROBOTICS, INC.
By: /S/ DAVID LAVITT By: /S/ SUSAN BRANA
David Lavitt Susan Brana
Title: Pres./CEO Title: Chairman of the Board
Date: 5/25/2000 Date: 5/25/2000
SCHEDULE "A"
List of Technologies Transferred
1. Taggant
2. Upgraded Taggant Reader
3. Shipping Sensors
